Penn Medicine

At 11 months following its launch, the Penn Medicine – Wharton Fund for Health is announcing investments in its fifth and sixth companies. Created as a joint initiative of Penn Medicine and the Wharton Social Impact Initiative to support…

Liver cancer’s rapid growth leads to a vulnerability in its energy-production and cell-building processes that may be potently exploited with a new combination-treatment strategy, according to a study from researchers at the Perelman…

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has selected Penn Medicine as one of five sites across the country to serve as a Center of Excellence for Influenza Research and…